Juno Therapeutics Cancer Trial Stops After 3 Deaths, But Other Gene Therapy Trials Continue

The FDA put a stop to a CAR-T cell therapy trial on leukemia sufferers after the deaths of three patients. Juno Therapeutics, the company behind the clinical trial, says it knows what caused the deaths and wants the trial to proceed with modifications.